Company profile for LPOXY Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

LPOXY Therapeutics, founded in 2020 by Dr. Larry D. Sutton and Dr. Porter W. Anderson Jr., is a biopharmaceutical company based in Platte City, Missouri. The company is developing LP-1002, an oral oxygen-delivery capsule designed to prevent Clostridioides difficile (C. diff) infections and treat inflammatory bowel diseases (IBD). LP-1002 works by gently increasing the colon's oxygen levels, creating an environment hostile to C...
LPOXY Therapeutics, founded in 2020 by Dr. Larry D. Sutton and Dr. Porter W. Anderson Jr., is a biopharmaceutical company based in Platte City, Missouri. The company is developing LP-1002, an oral oxygen-delivery capsule designed to prevent Clostridioides difficile (C. diff) infections and treat inflammatory bowel diseases (IBD). LP-1002 works by gently increasing the colon's oxygen levels, creating an environment hostile to C. diff bacteria, thereby inhibiting its growth and toxin production. The company has raised $28 million in Series A funding to advance clinical trials and bring this innovative therapy to market.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
13650 Wagon Pass Road, Platte City, MO 64079
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty